What is the share price of Adline Chem Lab Ltd (ADLINE) today?
The share price of ADLINE as on 15th July 2025 is ₹14.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Adline Chem Lab Ltd (ADLINE) share?
The past returns of Adline Chem Lab Ltd (ADLINE) share are- Past 1 week: -14.77%
- Past 1 month: -14.13%
- Past 3 months: 51.47%
- Past 6 months: -21.73%
- Past 1 year: -2.35%
- Past 3 years: 70.86%
- Past 5 years: 199.00%
What are the peers or stocks similar to Adline Chem Lab Ltd (ADLINE)?
The peers or stocks similar to Adline Chem Lab Ltd (ADLINE) include:What is the market cap of Adline Chem Lab Ltd (ADLINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Adline Chem Lab Ltd (ADLINE) is ₹8.75 Cr as of 15th July 2025.What is the 52 week high and low of Adline Chem Lab Ltd (ADLINE) share?
The 52-week high of Adline Chem Lab Ltd (ADLINE) is ₹26.01 and the 52-week low is ₹9.40.What is the PE and PB ratio of Adline Chem Lab Ltd (ADLINE) stock?
The P/E (price-to-earnings) ratio of Adline Chem Lab Ltd (ADLINE) is -67.28. The P/B (price-to-book) ratio is -5.87.Which sector does Adline Chem Lab Ltd (ADLINE) belong to?
Adline Chem Lab Ltd (ADLINE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Adline Chem Lab Ltd (ADLINE) shares?
You can directly buy Adline Chem Lab Ltd (ADLINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Adline Chem Lab Ltd
ADLINE Share Price
14.950.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ADLINE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ADLINE Performance & Key Metrics
ADLINE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -72.88 | -5.87 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.39 | 6.48 | 0.78% |
ADLINE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ADLINE Company Profile
Adline Chem Lab Ltd markets pharmaceutical products, including anti-infectives and veterinary medicines, with manufacturing capabilities for various forms.
SUNPHARMA
PE Ratio
37.34
37.34
1Y Return
7.71%
7.71%
Buy Reco %
84.85
84.85
CIPLA
PE Ratio
22.61
22.61
1Y Return
2.29%
2.29%
Buy Reco %
68.75
68.75
TORNTPHARM
PE Ratio
61.26
61.26
1Y Return
16.28%
16.28%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
54.42
54.42
1Y Return
24.10%
24.10%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.53
18.53
1Y Return
5.25%
5.25%
Buy Reco %
48.39
48.39
ADLINE Forecast
ADLINE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ADLINE
ADLINE
Income
Balance Sheet
Cash Flow
Annual Normal View
ADLINE Income Statement
ADLINE Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.26 | 8.31 | 5.84 | 14.80 | 6.33 | 2.07 | 1.00 | 0.00 | 0.25 | 0.25 | ||||||||||
Raw Materials | 13.12 | 5.04 | 2.46 | 3.25 | 2.33 | 0.35 | 0.00 | 0.00 | 0.00 | 0.33 | ||||||||||
| Power & Fuel Cost | 0.16 | 0.11 | 0.12 | 0.07 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 1.33 | 1.39 | 1.52 | 1.94 | 1.71 | 0.18 | 0.05 | 0.04 | 0.18 | |||||||||||
| Selling & Administrative Expenses | 0.48 | 0.45 | 0.90 | 1.19 | 1.08 | 0.23 | 0.07 | 0.13 | 0.11 | |||||||||||
| Operating & Other expenses | 0.87 | 0.24 | 0.00 | 11.42 | 1.41 | 0.26 | 5.02 | 0.01 | -0.00 | |||||||||||
EBITDA | 1.30 | 1.08 | 0.84 | -3.07 | -0.23 | 1.04 | -4.14 | -0.18 | -0.04 | -0.08 | ||||||||||
| Depreciation/Amortization | 0.96 | 0.73 | 0.73 | 0.42 | 1.02 | 0.35 | 0.09 | 0.00 | 0.00 | — | ||||||||||
| PBIT | 0.34 | 0.35 | 0.11 | -3.49 | -1.25 | 0.69 | -4.23 | -0.18 | -0.04 | -0.08 | ||||||||||
| Interest & Other Items | 0.32 | 0.34 | 0.07 | 0.02 | 0.03 | 0.01 | 0.00 | 0.12 | 0.16 | 0.12 | ||||||||||
| PBT | 0.02 | 0.01 | 0.04 | -3.51 | -1.28 | 0.68 | -4.23 | -0.30 | -0.20 | -0.20 | ||||||||||
| Taxes & Other Items | 0.00 | 0.01 | 0.00 | 0.26 | 0.00 | -0.05 | 0.00 | -0.03 | -0.07 | -0.08 | ||||||||||
| Net Income | 0.02 | 0.00 | 0.04 | -3.77 | -1.28 | 0.73 | -4.23 | -0.27 | -0.13 | -0.12 | ||||||||||
| EPS | 0.03 | 0.00 | 0.07 | -6.44 | -2.19 | 1.25 | -7.23 | -0.46 | -0.22 | -0.21 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ADLINE Company Updates
ADLINE Stock Peers
ADLINE Past Performance & Peer Comparison
ADLINE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Adline Chem Lab Ltd | -67.28 | -5.87 | — |
| Sun Pharmaceutical Industries Ltd | 37.34 | 5.63 | 0.94% |
| Cipla Ltd | 22.61 | 3.81 | 1.08% |
| Torrent Pharmaceuticals Ltd | 61.26 | 15.42 | 0.92% |
ADLINE Stock Price Comparison
Compare ADLINE with any stock or ETFCompare ADLINE with any stock or ETF
ADLINE
ADLINE Holdings
ADLINE Shareholdings
ADLINE Promoter Holdings Trend
ADLINE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ADLINE Institutional Holdings Trend
ADLINE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ADLINE Shareholding Pattern
ADLINE Shareholding Pattern
ADLINE Shareholding History
ADLINE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ADLINE stock
smallcases containing ADLINE stock
Looks like this stock is not in any smallcase yet.
ADLINE Events
ADLINE Events
ADLINE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADLINE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ADLINE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADLINE has not given any dividends in last 5 years
ADLINE Dividends
ADLINE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeADLINE Stock News & Opinions
ADLINE Stock News & Opinions
Articles & Videos
Corporate
Adline Chem Lab to hold AGM
Adline Chem Lab announced that the Annual General Meeting(AGM) of the company will be held on 22 July 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Adline Chem Lab AGM scheduled
Adline Chem Lab announced that the 37th Annual General Meeting(AGM) of the company will be held on 11 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Adline Chem Lab to convene board meeting
Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 13 June 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Adline Chem Lab reports standalone net profit of Rs 0.21 crore in the March 2025 quarter
Net profit of Adline Chem Lab reported to Rs 0.21 crore in the quarter ended March 2025 as against net loss of Rs 0.04 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.13 crore in the year ended March 2025 as against net loss of Rs 0.27 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Adline Chem Lab to hold board meeting
Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 9 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Adline Chem Lab to hold board meeting
Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 12 April 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Adline Chem Lab reports standalone net loss of Rs 0.12 crore in the December 2024 quarter
Net Loss of Adline Chem Lab reported to Rs 0.12 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Adline Chem Lab to hold board meeting
Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Adline Chem Lab schedules EGM
Adline Chem Lab announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 January 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Adline Chem Lab to table results
Adline Chem Lab will hold a meeting of the Board of Directors of the Company on 11 December 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -55.79%, vs industry avg of 10.15%
Over the last 5 years, market share decreased from 0.01% to 0%